Research Article
[Retracted] Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma
Table 2
Clinical and genomic characteristics of study population.
| Latent variables | Manifest variables | Description | Overall () |
| CLI | AGE () | Diagnosis age | | CLI | SEX (male) | Sex | 8 (44.4%) | MUT | ROBO1 | Candidate gene | 2 (11.1%) | MUT | KAT2B | Candidate gene | 2 (11.1%) | MUT | SETD1B | Candidate gene | 2 (11.1%) | MUT | GNA13 | Candidate gene | 2 (11.1%) | MUT | APBA1 | Candidate gene | 2 (11.1%) | MUT | MYD88 | Candidate gene | 6 (33.3%) | TRX | IniRT | Initial radiotherapy | 2 (11.1%) | TRX | IniST | Initial systemic treatment | 13 (72.2%) | TRX | SubRT | Subsequent radiotherapy | 6 (33.3%) | TRX | SubST | Subsequent systemic treatment | 3 (16.7%) |
|
|